Bank of New York Mellon
SNTI icon

Bank of New York Mellon’s Senti Biosciences Holdings SNTI Stock Holding History

Bank of New York Mellon’s Portfolio SNTI Stock Details SNTI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-1,237
Closed -$8.16K – 4303
2023
Q4 		$8.16K Hold
1,237
– – ﹤0.01% 4276
2023
Q3 		$5.11K Hold
1,237
– – ﹤0.01% 4328
2023
Q2 		$7.75K Hold
1,237
– – ﹤0.01% 4354
2023
Q1 		$14.6K Hold
1,237
– – ﹤0.01% 4332
2022
Q4 		$17.4K Buy
+1,237
New +$30.2K ﹤0.01% 4372

Other funds holding SNTI

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
8GI
8VC GP I Austin, Texas $39.6M AUM 36.39% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
IC
Intel Corp Santa Clara, California $470M AUM 21.74% 1-Year Est. Return
TM
Triatomic Management Palo Alto, California $3.39M AUM 3.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Bank of New York Mellon's SNTI Position: Q1 2024 in Review

Bank of New York Mellon sold out of Senti Biosciences Holdings (SNTI) in Q1 2024, closing a stake of 1,237 shares — an estimated $8.16K sold.

Bank of New York Mellon first reported a position in SNTI in Q4 2022 and held it in 5 quarters. The position peaked at $17.4K in Q4 2022. 27 funds tracked by Wall St. Rank hold SNTI as of Q1 2024.

  • Bank of New York Mellon reported no remaining Senti Biosciences Holdings position as of Q1 2024 after selling out during the quarter.
  • Bank of New York Mellon sold 1,237 Senti Biosciences Holdings shares in Q1 2024, an estimated $8.16K.
  • Bank of New York Mellon first reported a position in Senti Biosciences Holdings in Q4 2022 and held it in 5 quarters.
  • Bank of New York Mellon's Senti Biosciences Holdings position peaked at $17.4K in Q4 2022.
  • 27 funds tracked by Wall St. Rank held Senti Biosciences Holdings as of Q1 2024.

Based on Bank of New York Mellon's 13F filing for Q1 2024, filed 25 Apr 2024.